Clinical Operations
Patrick brings over 25 years of clinical trial experience in the biotech and pharmaceutical industry, with expertise in early-phase precision oncology development, CRO/vendor oversight, KOL engagement, budget planning, and clinical infrastructure. Prior to joining Atavistik Bio, Patrick was the Head of Development Operations at ImmunoGen, supporting their recent EU approval of mirvetuximab soravtansine. He has also held similar roles leading the clinical operations departments at Mersana Therapeutics and notably at Blueprint Medicines, where he built the clinical operations team from the ground up, playing a pivotal role in the clinical development of Avakyt and Gavreto from initial clinical trials through marketing approval in the US and EU.
Patrick began his career in clinical research as a genetic counselor, coordinating neurogenetic studies before moving into industry to support clinical trial management at Genetics Institute, and later at Millennium Pharmaceuticals.
Patrick holds a BS from Pennsylvania State University and a Master’s degree in Genetic Counseling from the University of Pittsburgh.